Sol-Gel Technologies (SLGL) Gains from Investment Securities (2016 - 2018)
Sol-Gel Technologies (SLGL) reported Gains from Investment Securities of $198575.0 for Q4 2018, down 76.63% year-over-year from $849780.0 in Q4 2017, and up 886.07% on a QoQ basis from $20138.0 in Q1 2018.
Sol-Gel Technologies (SLGL) has 3 years of Gains from Investment Securities data on file, last reported at $198575.0 in Q4 2018.
- Quarterly Gains from Investment Securities fell 76.63% year-over-year to $198575.0 in Q4 2018, while the trailing twelve-month figure through Dec 2018 was $198575.0 (down 76.63% YoY) and the FY2025 annual result came in at $54000.0, up 1250.0% from the prior year.
- Gains from Investment Securities advanced to $198575.0 in Q4 2018 per SLGL's latest filing, from $20138.0 in the prior quarter.
- Across five years, Gains from Investment Securities topped out at $849780.0 in Q4 2017 and bottomed at $20138.0 in Q1 2018.
- The 3-year median for Gains from Investment Securities is $300765.0 (2016), against an average of $367862.0.
- The widest annual swing landed in 2017, when Gains from Investment Securities surged 110.89%; it then sank 76.63% in 2018.
- Tracing SLGL's Gains from Investment Securities over 3 years: stood at $402955.0 in 2016, then soared by 110.89% to $849780.0 in 2017, then slumped by 76.63% to $198575.0 in 2018.
- Per Business Quant, the three latest SLGL Gains from Investment Securities figures stand at $198575.0 (Q4 2018), $20138.0 (Q1 2018), and $849780.0 (Q4 2017).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Quantum Biopharma | 1,216,509.61 Bn | 1,216,509.61 Bn | - |
| 2 | Alterity Therapeutics | 764,224.41 Bn | 764,224.38 Bn | - |
| 3 | Legend Biotech | 2,716.00 Bn | 2,715.71 Bn | 242.10 Mn |
| 4 | Nanobiotix | 2,248.83 Bn | 2,248.77 Bn | - |
| 5 | Akari Therapeutics | 1,951.18 Bn | 1,951.17 Bn | - |
| 6 | Vertex Pharmaceuticals | 113.69 Bn | 106.44 Bn | 2.59 Bn |
| 7 | Evaxion A | 64.16 Bn | 64.14 Bn | - |
| 8 | Regeneron Pharmaceuticals | 63.94 Bn | 55.18 Bn | 3.31 Bn |
| 9 | Alnylam Pharmaceuticals | 40.13 Bn | 37.12 Bn | 959.66 Mn |
| 10 | Sol-Gel Technologies | 205.76 Mn | 194.73 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2018 | 198,575.00 |
| Dec 31, 2018 | 198,575.00 |
| Mar 31, 2018 | 20,138.00 |
| Mar 31, 2018 | 20,138.00 |
| Dec 31, 2017 | 849,780.00 |
| Dec 31, 2017 | 849,780.00 |
| Dec 31, 2016 | 402,955.00 |
| Dec 31, 2016 | 402,955.00 |